The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy

被引：69

作者：

Lo, Angela Kwok-Fung ^{[1
]}

Dawson, Christopher W. ^{[2
]}

Lung, Hong Lok ^{[3
]}

Wong, Ka-Leung ^{[1
]}

Young, Lawrence S. ^{[2
]}

机构：

[1] Hong Kong Baptist Univ, Dept Chem, Hong Kong, Peoples R China

[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England

[3] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2021年 / 11卷

关键词：

Epstein-Barr virus; nasopharyngeal carcinoma; latent membrane protein 1; tumor microenvironment; therapy; EPSTEIN-BARR-VIRUS; LATENT MEMBRANE PROTEIN-1; NASOPHARYNGEAL CARCINOMA-CELLS; REGULATORY T-CELLS; INTERLEUKIN-10; EXPRESSION; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; HODGKIN LYMPHOMA; IMMUNE-RESPONSE; UP-REGULATION;

D O I：

10.3389/fonc.2021.640207

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The EBV-encoded latent membrane protein 1 (LMP1) is believed to play an important role in NPC pathogenesis by virtue of its ability to activate multiple cell signaling pathways which collectively promote cell proliferation and survival, angiogenesis, invasiveness, and aerobic glycolysis. LMP1 also affects cell-cell interactions, antigen presentation, and cytokine and chemokine production. Here, we discuss how LMP1 modulates local immune responses that contribute to the establishment of the NPC tumor microenvironment. We also discuss strategies for targeting the LMP1 protein as a novel therapy for EBV-driven malignancies.

引用

页数：17

共 143 条

[1] Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes [J].

Aga, M. ;

Bentz, G. L. ;

Raffa, S. ;

Torrisi, M. R. ;

Kondo, S. ;

Wakisaka, N. ;

Yoshizaki, T. ;

Pagano, J. S. ;

Shackelford, J. .

ONCOGENE, 2014, 33 (37) :4613-4622

[2] B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1 [J].

Ammous-Boukhris, Nihel ;

Mosbah, Amor ;

Ayadi, Wajdi ;

Sahli, Emna ;

Chevance, Soizic ;

Bondon, Arnaud ;

Gargouri, Ali ;

Baudy-Floc'h, Michele ;

Mokdad-Gargouri, Raja .

SCIENTIFIC REPORTS, 2019, 9 (1)

[3] Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells [J].

Ansari, Mairaj Ahmed ;

Singh, Vivek Vikram ;

Dutta, Sujoy ;

Veettil, Mohanan Valiya ;

Dutta, Dipanjan ;

Chikoti, Leela ;

Lu, Jie ;

Everly, David ;

Chandran, Bala .

JOURNAL OF VIROLOGY, 2013, 87 (15) :8606-8623

[4] Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation [J].

Arce-Sillas, Asiel ;

Denisse Alvarez-Luquin, Diana ;

Tamaya-Dominguez, Beatriz ;

Gomez-Fuentes, Sandra ;

Trejo-Garcia, Abel ;

Melo-Salas, Marlene ;

Cardenas, Graciela ;

Rodriguez-Ramirez, Juan ;

Adalid-Peralta, Laura .

JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016

[5] Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells [J].

Baumforth, Karl R. N. ;

Birgersdotter, Anna ;

Reynolds, Gary M. ;

Wei, Wenbin ;

Kapatai, Georgia ;

Flavell, Joanne R. ;

Kalk, Emma ;

Piper, Karen ;

Lee, Steve ;

Machado, Lee ;

Hadley, Kerry ;

Sundblad, Anne ;

Sjoberg, Jan ;

Bjorkholm, Magnus ;

Porwit, Anna A. ;

Yap, Lee-Fah ;

Teo, Soohwang ;

Grundy, Richard G. ;

Young, Lawrence S. ;

Ernberg, Ingemar ;

Woodman, Ciaran B. J. ;

Murray, Paul G. .

AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (01) :195-204

[6] Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue [J].

Benders A.A. ;

Tang W. ;

Middeldorp J.M. ;

Greijer A.E. ;

Thorne L.B. ;

Funkhouser W.K. ;

Rathmell W.K. ;

Gulley M.L. .

Head and Neck Pathology, 2009, 3 (4) :276-282

[7] Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins [J].

Bollard, Catherine M. ;

Gottschalk, Stephen ;

Torrano, Vicky ;

Diouf, Oumar ;

Ku, Stephanie ;

Hazrat, Yasmin ;

Carrum, George ;

Ramos, Carlos ;

Fayad, Luis ;

Shpall, Elizabeth J. ;

Pro, Barbara ;

Liu, Hao ;

Wu, Meng-Fen ;

Lee, Daniel ;

Sheehan, Andrea M. ;

Zu, Youli ;

Gee, Adrian P. ;

Brenner, Malcolm K. ;

Heslop, Helen E. ;

Rooney, Cliona M. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (08) :798-+

[8] Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis [J].

Burgos, JS .

MEDICAL ONCOLOGY, 2005, 22 (02) :113-121

[9] Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective [J].

Burks, Julian ;

Reed, Ryan E. ;

Desai, Shyamal D. .

ONCOTARGET, 2015, 6 (09) :7221-7231

[10] LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma [J].

Cai, Ting-Ting ;

Ye, Shu-Biao ;

Liu, Yi-Na ;

He, Jia ;

Chen, Qiu-Yan ;

Mai, Hai-Qiang ;

Zhang, Chuan-Xia ;

Cui, Jun ;

Zhang, Xiao-Shi ;

Busson, Pierre ;

Zeng, Yi-Xin ;

Li, Jiang .

PLOS PATHOGENS, 2017, 13 (07)

← 1 2 3 4 5 6 7 8 9 10 →